American International Group, Inc. Homology Medicines, Inc. Transaction History

American International Group, Inc.

$27.6 Billion
Q1 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$1.39 - $3.12 $28,948 - $64,977	-20,826 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$2.6 - $4.17 $3,809 - $6,109	-1,465 Reduced 6.57%	20,826 $63,000
Q4 2021 Feb 11, 2022	SELL	$3.64 - $7.78 $2,427 - $5,189	-667 Reduced 2.91%	22,291 $81,000
Q3 2021 Nov 12, 2021	SELL	$6.01 - $8.71 $3,287 - $4,764	-547 Reduced 2.33%	22,958 $181,000
Q2 2021 Aug 13, 2021	BUY	$6.02 - $9.64 $22,243 - $35,619	3,695 Added 18.65%	23,505 $171,000

Q1 2021 May 07, 2021	BUY	$9.17 - $14.8 $476 - $769	52 Added 0.26%	19,810 $186,000
Q4 2020 Feb 12, 2021	SELL	$8.92 - $13.29 $5,057 - $7,535	-567 Reduced 2.79%	19,758 $223,000
Q3 2020 Nov 04, 2020	SELL	$9.94 - $16.59 $4,592 - $7,664	-462 Reduced 2.22%	20,325 $218,000
Q2 2020 Aug 12, 2020	BUY	$12.07 - $19.34 $73,759 - $118,186	6,111 Added 41.64%	20,787 $316,000
Q1 2020 May 04, 2020	SELL	$12.5 - $22.04 $10,612 - $18,711	-849 Reduced 5.47%	14,676 $228,000
Q4 2019 Feb 05, 2020	SELL	$11.42 - $22.19 $1,496 - $2,906	-131 Reduced 0.84%	15,525 $321,000
Q3 2019 Nov 08, 2019	BUY	$14.74 - $22.28 $2,889 - $4,366	196 Added 1.27%	15,656 $283,000
Q2 2019 Aug 13, 2019	BUY	$18.35 - $30.34 $82,685 - $136,712	4,506 Added 41.14%	15,460 $303,000
Q1 2019 May 06, 2019	SELL	$19.76 - $29.57 $7,034 - $10,526	-356 Reduced 3.15%	10,954 $304,000
Q4 2018 Feb 13, 2019	BUY	$18.39 - $26.3 $80,548 - $115,194	4,380 Added 63.2%	11,310 $253,000
Q3 2018 Nov 09, 2018	BUY	$15.54 - $22.86 $1,942 - $2,857	125 Added 1.84%	6,930 $158,000
Q2 2018 Aug 08, 2018	BUY	$16.49 - $21.55 $112,214 - $146,647	6,805 New	6,805 $139,000

Others Institutions Holding FIXX

# of Institutions

Shares Held

66.2K

Call Options Held

Put Options Held

View Full List

About Homology Medicines, Inc.

Ticker FIXX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 57,402,000
Description
Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nucleas...

More about FIXX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.

Account